Does allergic rhinitis exist in infancy? Findings from the PARIS birth cohort

M Herr1, B Clarisse, L Nikasinovic

  • 1Laboratoire Santé Publique et Environnement, Faculté des Sciences Pharmaceutiques et Biologiques,Université Paris Descartes, 4 avenue de l’Observatoire, Paris, France.

Allergy
|September 1, 2010
PubMed

Insights

Allergic rhinitis (AR) symptoms can appear in toddlers as young as 18 months. Early diagnosis is supported by a family history of AR or biological markers like blood eosinophilia and sensitization to allergens.

Area of Science:

  • Pediatric Allergy and Immunology
  • Environmental Health
  • Epidemiology

Background:

  • Early onset of allergic rhinitis (AR) is understudied, with symptoms often misattributed to infections.
  • The PARIS (Pollution and Asthma Risk: an Infant Study) birth cohort provides a unique dataset to investigate infant atopy and AR-like symptoms.

Purpose of the Study:

  • To analyze the relationship between allergic rhinitis-like symptoms and atopy in infants.
  • To identify early indicators for allergic rhinitis in toddlers.

Main Methods:

  • AR-like symptoms (rhinorrhea, nasal congestion, sneezing) were assessed via questionnaire at 18 months in the PARIS cohort.
  • Parental allergy history and infant atopy markers (blood eosinophilia, total IgE, specific IgE) were evaluated.
  • Multivariate logistic regression adjusted for confounders was used to study associations.

Main Results:

  • 9.1% of 1850 toddlers reported AR-like symptoms in the past year.
  • Parental history of AR significantly increased the risk (OR 2.09).
  • Biological markers of atopy, particularly blood eosinophilia and house dust mite sensitization, were strongly associated with AR-like symptoms.

Conclusions:

  • Allergic rhinitis can manifest as early as 18 months of age.
  • Infants with a parental history of AR or biological evidence of atopy, especially blood eosinophilia and inhalant allergen sensitization, warrant increased suspicion for AR.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Allergic Reactions02:06

Allergic Reactions

Overview
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...